-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
PharmaCielo Enters Spanish Market With Initial Shipment Of 300Kg Of CBD Full Spectrum Oil To Extractions Solutions
PharmaCielo Enters Spanish Market With Initial Shipment Of 300Kg Of CBD Full Spectrum Oil To Extractions Solutions
PharmaCielo Ltd. (OTCQX:PCLOF) (TSXV:PCLO) , the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. has made an initial shipment of CBD full spectrum oil containing THC to Extractions Solutions SL, a Spanish natural pharmaceutical company that specializes in the post-processing and refinement of cannabis derivatives. Extractions Solutions intends to use PharmaCielo's product to develop CBD derivatives to be produced in Spain, and distributed across Europe.
Bill Petron, CEO of PharmaCielo, stated, "We are pleased to announce our entrance into a new market, with the initial shipment of PharmaCielo API to Extractions Solutions, in support of their product development efforts. This serves to further expand our distribution network throughout Europe, building on our recent announcements that we will be bringing PharmaCielo products to the German and Polish medical cannabis markets. Our sales team has already made substantial progress in the first five months of 2022, and we expect to continue this trend through the rest of the year as we drive toward increased revenues and sustained profitability."
Dirk Eduard M. de Maeyer, executive director of Extractions Solutions, said his company was pleased to expand its product portfolio. "Extractions Solutions is an innovative, rapidly growing cannabinoid post-processor, refiner and manufacturer, with an established customer base across the European market. With a commitment to providing high quality products and custom solutions, as well as seed to solution traceability, PharmaCielo was a logical choice as we continue to build-out our product portfolio. PharmaCielo has the quality, consistency, sophistication and scale that we require of our API partners, and we look forward to continuing to advance the relationship as we seek to serve our customers across the EU, and globally," stated Maeyer.
Photo: Courtesy of Richard T on Unsplash
Related News
PharmaCielo To Enter Polish Medical Cannabis Market Via Partnership With Soteria Holdings
PharmaCielo Cuts Net Loss By 39.13% To $20.9M Despite Plummeting Revenues In 2021
Colombia's Flora Growth & PharmaCielo Begin Exporting Dried Flower As New Rules Take Effect
PharmaCielo Ltd. (OTCQX:PCLOF) (TSXV:PCLO) , the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. has made an initial shipment of CBD full spectrum oil containing THC to Extractions Solutions SL, a Spanish natural pharmaceutical company that specializes in the post-processing and refinement of cannabis derivatives. Extractions Solutions intends to use PharmaCielo's product to develop CBD derivatives to be produced in Spain, and distributed across Europe.
PharmaCielo有限公司。(OTCQX:PCLOF)(多倫多證券交易所股票代碼:PCLO),哥倫比亞乾花和藥用級大麻提取物的主要種植者和生產商的加拿大母公司,PharmaCielo哥倫比亞控股公司有製造了第一批CBD全光譜油含THC 至Exttions Solutions SL,一家西班牙天然製藥公司,專門從事大麻衍生品的後處理和提煉。Exctions Solutions打算使用PharmaCielo的產品開發CBD衍生品,這些衍生品將在西班牙生產,並在歐洲各地分銷。
Bill Petron, CEO of PharmaCielo, stated, "We are pleased to announce our entrance into a new market, with the initial shipment of PharmaCielo API to Extractions Solutions, in support of their product development efforts. This serves to further expand our distribution network throughout Europe, building on our recent announcements that we will be bringing PharmaCielo products to the German and Polish medical cannabis markets. Our sales team has already made substantial progress in the first five months of 2022, and we expect to continue this trend through the rest of the year as we drive toward increased revenues and sustained profitability."
比爾·彼得龍PharmaCielo的首席執行官説:“我們很高興地宣佈進入一個新的市場,PharmaCielo的第一批原料藥將運往提取解決方案公司,以支持他們的產品開發工作。這有助於進一步擴大我們在整個歐洲的分銷網絡,基於我們最近宣佈我們將把PharmaCielo的產品引入德國和波蘭醫用大麻市場。我們的銷售團隊在2022年的前五個月已經取得了重大進展,我們預計在今年餘下的時間裏將繼續這一趨勢,我們將努力實現收入的增加和持續的盈利。”
Dirk Eduard M. de Maeyer, executive director of Extractions Solutions, said his company was pleased to expand its product portfolio. "Extractions Solutions is an innovative, rapidly growing cannabinoid post-processor, refiner and manufacturer, with an established customer base across the European market. With a commitment to providing high quality products and custom solutions, as well as seed to solution traceability, PharmaCielo was a logical choice as we continue to build-out our product portfolio. PharmaCielo has the quality, consistency, sophistication and scale that we require of our API partners, and we look forward to continuing to advance the relationship as we seek to serve our customers across the EU, and globally," stated Maeyer.
德克·愛德華·M·德·梅耶董事高管Exctions Solutions表示,他的公司很高興擴大其產品組合。Maeyer説:“Exttions Solutions是一家創新的、快速發展的大麻後處理器、精煉商和製造商,在歐洲市場擁有穩固的客户基礎。PharmaCielo致力於提供高質量的產品和定製解決方案,以及種子到解決方案的可追溯性,在我們繼續擴大我們的產品組合時,PharmaCielo是一個合乎邏輯的選擇。PharmaCielo擁有我們對原料藥合作伙伴所要求的質量、一致性、成熟度和規模,我們期待着在我們尋求為整個歐盟和全球客户服務的同時,繼續推進我們的關係。”
Photo: Courtesy of Richard T on Unsplash
圖片:由Richard T在UnSplash上提供
Related News
相關新聞
PharmaCielo To Enter Polish Medical Cannabis Market Via Partnership With Soteria Holdings
PharmaCielo將通過與Soteria控股公司的合作進入波蘭醫用大麻市場
PharmaCielo Cuts Net Loss By 39.13% To $20.9M Despite Plummeting Revenues In 2021
PharmaCielo將淨虧損減少39.13%,至2090萬美元,儘管2021年收入暴跌
Colombia's Flora Growth & PharmaCielo Begin Exporting Dried Flower As New Rules Take Effect
隨着新規生效,哥倫比亞的Flora Growth和PharmaCielo開始出口乾花
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧